Tyra Biosciences Inc.

8.68
-0.04 (-0.46%)
At close: Apr 02, 2025, 3:59 PM
8.80
1.39%
After-hours: Apr 02, 2025, 07:56 PM EDT

Tyra Biosciences Statistics

Share Statistics

Tyra Biosciences has 50.75M shares outstanding. The number of shares has increased by -3.29% in one year.

Shares Outstanding 50.75M
Shares Change (YoY) -3.29%
Shares Change (QoQ) -4.01%
Owned by Institutions (%) 82.57%
Shares Floating 30.76M
Failed to Deliver (FTD) Shares 27.25K
FTD / Avg. Volume 9.23%

Short Selling Information

The latest short interest is 2.77M, so 5.24% of the outstanding shares have been sold short.

Short Interest 2.77M
Short % of Shares Out 5.24%
Short % of Float 9.02%
Short Ratio (days to cover) 10.8

Valuation Ratios

The PE ratio is -9.2 and the forward PE ratio is -7.78. Tyra Biosciences's PEG ratio is 1.35.

PE Ratio -9.2
Forward PE -7.78
PS Ratio 0
Forward PS 1.6
PB Ratio 2.32
P/FCF Ratio -11.29
PEG Ratio 1.35
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tyra Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 23.81, with a Debt / Equity ratio of 0.02.

Current Ratio 23.81
Quick Ratio 23.81
Debt / Equity 0.02
Debt / EBITDA -0.06
Debt / FCF -0.09
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.44M
Employee Count 60
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by -50.68% in the last 52 weeks. The beta is 1.09, so Tyra Biosciences's price volatility has been higher than the market average.

Beta 1.09
52-Week Price Change -50.68%
50-Day Moving Average 12.09
200-Day Moving Average 17.34
Relative Strength Index (RSI) 25.08
Average Volume (20 Days) 295.28K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -104.18M
Net Income -86.48M
EBITDA -104.18M
EBIT n/a
Earnings Per Share (EPS) -1.51
Full Income Statement

Balance Sheet

The company has 91.97M in cash and 6.22M in debt, giving a net cash position of 85.74M.

Cash & Cash Equivalents 91.97M
Total Debt 6.22M
Net Cash 85.74M
Retained Earnings -251.31M
Total Assets 363.56M
Working Capital 332.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -69.77M and capital expenditures -664K, giving a free cash flow of -70.44M.

Operating Cash Flow -69.77M
Capital Expenditures -664K
Free Cash Flow -70.44M
FCF Per Share -1.23
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TYRA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for TYRA is $30.5, which is 251.4% higher than the current price. The consensus rating is "Buy".

Price Target $30.5
Price Target Difference 251.4%
Analyst Consensus Buy
Analyst Count 6
Stock Forecasts

Scores

Altman Z-Score 12.2
Piotroski F-Score 2